vimarsana.com

Latest Breaking News On - Captar - Page 1 : vimarsana.com

AptarGroup, Inc (NYSE:ATR) Q4 2023 Earnings Call Transcript

AptarGroup, Inc. (NYSE:ATR) Q4 2023 Earnings Call Transcript February 9, 2024 AptarGroup, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Aptar’s 2023 Fourth Quarter Conference Call. At this time, […]

Twibright Optar

AptarGroup : Voluntis and Tilak Healthcare Partner to Help Cancer Patients Better Manage Ocular Toxicities

Voluntis, an Aptar Pharma company and leader in digital therapeutics, today announced a partnership with Tilak Healthcare, a digital therapeutics company specializing in clinically. | February 23, 2022

AptarGroup : Optimizing Your Pre-Clinical Discovery in Pulmonary and Nasal Drug Development

Join this webinar to discover more about these scientific guidelines and how Aptar Pharma s innovative devices for non-clinical research can meet unmet pharmaceutical needs and. | December 16, 2021

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.